European Regulatory Agency Grants Orphan Status to Morphotek®'s FARLETUZUMAB (MORAb-003) and MORAb-009
[ 2008/04/16 | Eisai Co., Ltd. | Pharmaceuticals | Tokyo | TSE1(PRIME) ]

The Company's Official Page
http://www.eisai.co.jp/enews/enews200821.html
Back To Previous Page
Dear User,
JPubb program could not collect the texts of this press-release from the official page, which perhaps mainly comprises tables, charts or images. Please refer to the official page indicated above. -- by JPubb

Latest News: Pharmaceuticals

    この内容でのリリース掲載はまだ無いか、集計されておりません。

more
    この内容でのリリース掲載はまだ無いか、集計されておりません。

more

Most Popular: Pharmaceuticals

1. KAKEN PHARMACEUTICAL CO. and ELITRA PHAR...
Kaken Pharmaceutical Co.,Ltd. 2003/02/20
2. Launching of ゛MIROL Ophth. Soln. 0.5%&qu...
Kaken Pharmaceutical Co.,Ltd. 2001/02/21
3. KAKEN PHARMACEUTICAL CO., LTD. and the I...
Kaken Pharmaceutical Co.,Ltd. 2000/12/14
4. Daiichi Pharmaceutical Transfers Manufac...
Kaken Pharmaceutical Co.,Ltd. 2000/02/24
5. Taisho to Acquire the Company's Own...
Taisho Pharmaceutical Holdings Co., Ltd. 2009/03/03

Latest News: Eisai Co., Ltd.


more

Most Popular: Eisai Co., Ltd.

1. FDA Accepts for Review Eisai's NDA ...
2009/11/25

Categories

Go to Page Top

View: Smartphone | PC

Language: English | Japanese

■Home

■Terms & Conditions

■Twitter ■Facebook

■About Us